MedTrace Logo

Multicenter Study of Cryoablation for Palliation of Painful Bone Metastases

NCT02511678 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2021-07-19

Study results available
· View outcomes & findings →

Summary

This study will evaluate the efficacy of cryoablation for palliation of painful metastases in participants with metastatic lesions involving bone who have failed, are not candidates for, or are not experiencing adequate pain relief from current pain therapies (for example, radiation, analgesics).

Conditions

  • Pain
  • Neoplasm Metastasis
  • Bone Metastasis of Diverse Origins

Interventions

DEVICE

Cryoablation

The application of repeated freeze and thaw cycles to the identified tissues.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Jack Jennings, MD · Washington University Saint Louis

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-15
Primary Completion
2018-03-12
Completion
2018-03-12

Countries

  • United States
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02511678 on ClinicalTrials.gov